These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9135545

  • 1. Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo.
    Belfrage H, Dohlsten M, Hedlund G, Kalland T.
    Immunology; 1997 Feb; 90(2):183-8. PubMed ID: 9135545
    [Abstract] [Full Text] [Related]

  • 2. Superantigens anergize cytokine production but not cytotoxicity in vivo.
    Sundstedt A, Dohlsten M, Hedlund G, Höidén I, Björklund M, Kalland T.
    Immunology; 1994 May; 82(1):117-25. PubMed ID: 7913912
    [Abstract] [Full Text] [Related]

  • 3. Superantigen-induced anergy in cytotoxic CD8+ T cells.
    Sundstedt A, Höidén I, Hansson J, Hedlund G, Kalland T, Dohlsten M.
    J Immunol; 1995 Jun 15; 154(12):6306-13. PubMed ID: 7759869
    [Abstract] [Full Text] [Related]

  • 4. Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo.
    Belfrage H, Dohlsten M, Hedlund G, Kalland T.
    Cancer Immunol Immunother; 1995 Aug 15; 41(2):87-94. PubMed ID: 7656274
    [Abstract] [Full Text] [Related]

  • 5. Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment.
    Belfrage H, Dohlsten M, Hedlund G, Kalland T.
    Cancer Immunol Immunother; 1997 Apr 15; 44(2):77-82. PubMed ID: 9177468
    [Abstract] [Full Text] [Related]

  • 6. Immune response during tumor therapy with antibody-superantigen fusion proteins.
    Rosendahl A, Hansson J, Sundstedt A, Kalland T, Dohlsten M.
    Int J Cancer; 1996 Sep 27; 68(1):109-13. PubMed ID: 8895549
    [Abstract] [Full Text] [Related]

  • 7. Response of T cells in vivo induced by repeated superantigen treatments at different time intervals.
    Huang Y, Sui Y, Zhang X, Si S, Ge W, Hu P, Li X, Ma B.
    Acta Biochim Biophys Sin (Shanghai); 2007 Jul 27; 39(7):467-74. PubMed ID: 17622466
    [Abstract] [Full Text] [Related]

  • 8. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
    Dohlsten M, Björklund M, Sundstedt A, Hedlund G, Samson D, Kalland T.
    Immunology; 1993 Aug 27; 79(4):520-7. PubMed ID: 7691731
    [Abstract] [Full Text] [Related]

  • 9. Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity.
    Belfrage H, Bhiladvala P, Hedlund G, Dohlsten M, Kalland T.
    Cancer Immunol Immunother; 1994 Apr 27; 38(4):265-71. PubMed ID: 8168122
    [Abstract] [Full Text] [Related]

  • 10. Interaction between superantigen and T-cell receptor Vbeta element determines levels of superantigen-dependent cell-mediated cytotoxicity of CD8(+) T cells in induction and effector phases.
    Li ZJ, Omoe K, Shinagawa K, Yagi J, Imanishi K.
    Microbiol Immunol; 2009 Aug 27; 53(8):451-9. PubMed ID: 19659929
    [Abstract] [Full Text] [Related]

  • 11. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
    Kuroda K, Yagi J, Imanishi K, Yan XJ, Li XY, Fujimaki W, Kato H, Miyoshi-Akiyama T, Kumazawa Y, Abe H, Uchiyama T.
    J Immunol; 1996 Aug 15; 157(4):1422-31. PubMed ID: 8759722
    [Abstract] [Full Text] [Related]

  • 12. Bacterial superantigens reactivate antigen-specific CD8+ memory T cells.
    Coppola MA, Blackman MA.
    Int Immunol; 1997 Sep 15; 9(9):1393-403. PubMed ID: 9310843
    [Abstract] [Full Text] [Related]

  • 13. The role of IL-4 in the staphylococcal enterotoxin B-triggered immune response: increased susceptibility to shock and deletion of CD8Vbeta8+ T cells in IL-4 knockout mice.
    Aroeira LS, Martínez-A C.
    Eur J Immunol; 1999 Apr 15; 29(4):1397-405. PubMed ID: 10229108
    [Abstract] [Full Text] [Related]

  • 14. Induction of responsiveness in superantigen-induced anergic T cells. Role of ligand density and costimulatory signals.
    Heeg K, Wagner H.
    J Immunol; 1995 Jul 01; 155(1):83-92. PubMed ID: 7602125
    [Abstract] [Full Text] [Related]

  • 15. Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B.
    Hamel ME, Eynon EE, Savelkoul HF, van Oudenaren A, Kruisbeek AM.
    Int Immunol; 1995 Jul 01; 7(7):1065-77. PubMed ID: 8527404
    [Abstract] [Full Text] [Related]

  • 16. Repeated treatment with antibody-targeted superantigens strongly inhibits tumor growth.
    Rosendahl A, Kristensson K, Hansson J, Ohlsson L, Kalland T, Dohlsten M.
    Int J Cancer; 1998 Apr 13; 76(2):274-83. PubMed ID: 9537591
    [Abstract] [Full Text] [Related]

  • 17. Active suppression induced by cutaneous exposure to bacterial superantigen is prevented by interleukin-12 treatment in vivo.
    Saloga J, Enk AH, Becker D, Bellinghausen I, Kühn S, Knop J.
    Immunology; 1998 Apr 13; 93(4):485-92. PubMed ID: 9659219
    [Abstract] [Full Text] [Related]

  • 18. Superantigen-reactive T cells that display an anergic phenotype in vitro appear functional in vivo.
    Heeg K, Gaus H, Griese D, Bendigs S, Miethke T, Wagner H.
    Int Immunol; 1995 Jan 13; 7(1):105-14. PubMed ID: 7718507
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S, Seelig M, Lee HM, Lin J.
    J Immunol; 1995 Jul 15; 155(2):609-18. PubMed ID: 7608539
    [Abstract] [Full Text] [Related]

  • 20. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
    Sundstedt A, Grundström S, Dohlsten M.
    Immunology; 1998 Sep 15; 95(1):76-82. PubMed ID: 9767460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.